Dr. Clarence B. Glenn III, MD, MBA

Expertise

• Emotional and thought disorder
• Addiction
• Child and adolescent psychiatry

Treatment Orientation

• Psychotherapy
• Medication

Work experience

• February 2020 – Present
  Co-Founder of Galère Capital Group, LLC
  Los Angeles, CA
  
  Prospecting new investment opportunities.
  Performing due diligence on potential investments.
  Analyzing and determining the feasibility of different start-up financial models.
• February 2019 – June 2020
  Healthcare Consultant (Freelance)
  NYC Health + Hospitals
  New York, NY
  
  Consulted on multiple mental health projects with newly allocated funds.
• July 2018 – June 2021
  Resident Physician
  Los Angeles County
  Dept. of Mental Health
  Los Angeles, CA
  
  Rotating through multiple psychiatric subspecialty facilities throughout LA county,
  providing treatment for a variety of emotional and thought disorders in the forensic, addiction, and child & adolescent settings.
• June 2015 – December 2015
  Student Research Fellow
  Weill-Cornell Medical College
  New York, NY
  
  Performed research investigating evidence of the presence of both spermatogonial stem cells and spermatogonia in the testes of male patients with Sertoli cell-only syndrome, indicating an arrest in cell maturation as a newly hypothesized disease mechanism.
• August 2012 – July 2013
  Research Assistant
  Georgia State Univ Neuroscience Institute Atlanta GA
  
  Performed research investigating the role of sensory input in the early development of the visual system of transgenic mice.
  Used immunohistochemical techniques to prepare, fix and image neural tissues Performed experiments to measure modifications to the visual field parameters of mice with lesions to the superior colliculus.
  Performed autoradiography studies to identify the presence and functionality of GABAc receptors in the brains of lesioned, transgenic animals.
• March 2011 – June 2012
  Research Assistant
  Wayne State Univ School of Medicine
  Detroit, MI
  
  Performed research into the physiological mechanisms that underlie sleep apnea syndrome in humans.
  Consented and familiarized subjects with experimental protocols in accordance with w/HIPAA regulations.
  Performed quality control and administrative duties regarding the IRB Formulated and edited scopes of practice.
  Performed polysomnography studies.
  Gained proficiency with the scoring of sleep and associated events in accordance with the standards set forth by the American Academy of Sleep Medicine.
  Examined various physiological parameters of the respiratory system, including the carbon dioxide reserve, apneic threshold, carotid baroreceptor sensitivity, and multiple forms of respiratory plasticity.
  Calibrated equipment and analyzed data using the WINDAQ and Grass42 software programs.
  Gained advanced proficiency with Microsoft Excel and PowerPoint for data analysis and presentation purposes.
  Presented data at various symposiums and conferences.

Education

• August 2003 – May 2008
  Bachelor of Science
  Biomedical Science/Spanish
  Central Michigan University
  Mount Pleasant, MI
• September 2009 – April 2011
  Post-Baccalaureate Studies
  Physiology
  Wayne State University
  Detroit, MI
• July 2013 – May 2017
  Medical Doctorate
  Howard University College of Medicine
  Medicine – Psychiatry
  Washington, DC.
• June 2018 – June 2021
  Psychiatry Residency
  Charles R. Drew Los Angeles,
  University of Medicine & Science
  CA
• September 2021 – July 2022
  Venture Capital and Private Equity Program
  Columbia Business School
  New York, NY
• April 2017 – June 2018
  Master of Business Administration
  Kogod School of Business
  American University
  Finance/Behavioral Economics